DCT 2/3 Study Session Pharmacy in Dentistry (NWDCT2/3170315P)
Availability | Course has taken place |
Subject | Pharmacology |
Description | An Update on Pharmacy issues in Dentistry |
Additional information | This is a study session for DCT2/3s only Please arrive at 1.45pm for registration |
Venue | Upper Lecture Theatre, Liverpool University Dental Hospital, Liverpool - Merseyside ![]() |
Date & time | Wednesday 15 March 2017, 14:00 to 17:00 |
Lecturer | Christine Randall ![]() |
Target audience | Mandatory: Dental Core Trainee Year 1, or Dental Core Trainee Year 2/3 |
Development outcome | No development outcome |
Course style | Lecture![]() |
Core topic | Not a core topic |
Catering | None |
CPD hours | 3:00 |
Cost | No charge |
Aims | Focusing on issues relevant to the dental team, to raise awareness of: • The laws that apply to medicines • Drug interactions • Oral adverse reactions to medicines • Concerns around commonly taken and used medicines |
Objectives | • To manage and prescribe medicines within the current legal framework. Medicines and prescribing are highly regulated in the UK and knowing which aspects of the law are relevant to dental practice is essential. The session will cover: • The legal framework for medicines. • Prescription and supply of medicines privately and on NHS prescription. • Patient Group Directions (PGDs). • Controlled drugs in dental practice e.g. midazolam. • Resources for medicines information. • To minimise risk to patients by raising awareness of drug interactions when prescribing and administering medicines. All medicines have the potential to cause or be affected by drug interactions. Some of the drug interactions that are clinically relevant and impact most in dental practice will be discussed. • To identify some important oral adverse drug reactions and report them appropriately to the Yellow Card Scheme. All medicines cause adverse effects – not in all patients and not always severe. Adverse drug reactions (ADRs) that may be seen by the dental team are highlighted including osteonecrosis of the jaw associated with bisphosphonates. Reporting ADRs is an important professional responsibility for all members of the dental healthcare team and how this should be done via the MHRA’s Yellow Card Scheme will be described. • To recognise areas of concern when treating patients on medicines or using medicines to treat patients. Patients taking medicines can provide challenges for the dental team but sometimes appropriate use of commonly used medicines is also unclear, the following will be covered: • anticoagulants/antiplatelets including the new oral anticoagulants • lidocaine, maximum dose and contraindications • corticosteroids • analgesics – choice, use and effectiveness for dental pain • dental antib |
Learning outcomes | To have an appreciation of the objectives listed above. |